This is comparable to high risk populations identified through genetic testing; the lifetime risk for ovarian cancer increases 27 and 11 times with BRCA1 and BRCA2 mutations, respectively (Kuchenbaecker et al., 2017). The gene discussed is BRCA2; the disease is ovarian cancer.